Pulmonary arterial hypertension (PAH) is a disease of the lung blood vessels that results in
right heart failure. PAH is thought to occur in about 5% to 10% of patients with hepatosplenic …

Abstract According to the World Symposium Pulmonary Hypertension (WSPH) classification,
pulmonary hypertension (PH) is classified into five categories based on etiology. Among …

Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by
progressive pulmonary artery (PA) remodeling. T helper 2 cell (Th2) immune response is …

Background Inflammation underlies many forms of pulmonary hypertension (PH), including
that resulting from Schistosoma infection, a major cause of PH worldwide. Schistosomiasis …

Cardiovascular diseases are the leading cause of death worldwide. A chronic inflammatory
response is a common pathological alteration in diverse cardiovascular diseases …

Schistosomiasis, especially due to Schistosoma mansoni, is a well-recognized cause of
pulmonary arterial hypertension (PAH). The high prevalence of this helminthiasis makes …

In the last decades, important advances have been made in the treatment of pulmonary
arterial hypertension (PAH), a severe, progressive, incurable, and potentially fatal disease …

Approximately 5% of individuals chronically infected with Schistosoma mansoni develop
pulmonary hypertension (PH). The disease is progressive and often fatal, and treatment …

Pulmonary hypertension (PH) is a hemodynamic condition characterized by the presence of
mean pulmonary artery pressure≥ 25 mm Hg. Many different baseline conditions and/or risk …

There is urgent need for pulmonary hypertension advocacy among clinicians in the primary,
secondary and tertiary healthcare sectors of majority countries, and validated noninvasive …